Proteomics

• Page 3 of 3 (25 items) First 1 2 3 

• Need for Novel Approaches to Treating HIV Still Exists
  As resistance continues to be a problem, firms are trying to exploit characteristics that allow the virus to adapt seemingly endlessly.
• Sutent—Would Biomarkers Have Helped?
  Recent failures bear out the necessity for marker development alongside drug R&D but also highlight the complexities.
• Top-10 Session Picks for the 2009 BIO International Convention
  Topics cover new science policy initiatives, global financial issues, and novel trends.
• Final Stimulus Package Provides $21.5B for Research
  Biggest winner seems to be the NIH, which will receive $8.5 billion for research grants.
• Barack to Business in 2009
  At least for the biotech sector, change is certainly here.

• Page 3 of 3 (25 items) First 1 2 3